The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Open accessAbstract
We have reported previously that the hepatitis B virus oncoprotein, HBx, can bind to the C terminus of p53 and inhibit several critical p53-mediated cellular processes, including DNA sequence-specific binding, transcriptional transactivation, and apoptosis. Recognizing the importance of p53-mediated apoptosis for maintaining homeostasis and preventing neoplastic transformation, here we further examine the physical interaction between HBx and p53 as well as the functional consequences of this association. In vitro binding studies indicate that the ayw and adr viral subtypes of HBx bind similar amounts of glutathione S -transferase-p53 with the distal C terminus of HBx (from residues 111 to 154) being critical for this interaction. Using a microinjection technique, we show that this same C-terminal region of HBx is necessary for sequestering p53 in the cytoplasm and abrogating p53-mediated apoptosis. The transcriptional transactivation domain of HBx also maps to its C terminus; however, a comparison of the ability of full-length and truncated HBx protein to abrogate p53-induced apoptosis versus transactivate simian virus 40- or human nitric oxide synthase-2 promoter-driven reporter constructs indicates that these two functional properties are distinct and thus may contribute to hepatocarcinogenesis differently. Collectively, our data indicate that the distal C-terminal domain of HBx, independent of its transactivation activity, complexes with p53 in the cytoplasm, partially preventing its nuclear entry and ability to induce apoptosis. These pathobiological effects of HBx may contribute to the early stages of hepatocellular carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Self-citationNitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Self-citationSelective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Miura, M. (1993) · Cell · doi:10.1016/0092-8674(93)90486-a · Cited by 1,373
DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors
Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., et al. (1991) · Science · doi:10.1126/science.1948068 · Cited by 1,234
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
DNA damage and mutation in human cells exposed to nitric oxide in vitro.
Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., & Tannenbaum, S. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3030 · Cited by 974
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735
Harris, C. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1442 · Cited by 680
Self-citationWang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Self-citationInduction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
Self-citationHBV X Protein Alters the DNA Binding Specificity of CREB and ATF-2 by Protein-Protein Interactions
Maguire, H. F., Hoeffler, J. P., & Siddiqui, A. (1991) · Science · doi:10.1126/science.1827531 · Cited by 454
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
Nussler, A. K., Di Silvio, M., Billiar, T. R., Hoffman, R. A., Geller, D. A., Selby, R., Madariaga, J., & Simmons, R. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.1.261 · Cited by 420
Self-citationFunctional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Self-citationThe XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.
Wang, X. W., Vermeulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J. H., et al. (1996) · Genes & Development · doi:10.1101/gad.10.10.1219 · Cited by 313
Self-citationFeitelson, M. A., Zhu, M., Duan, L., & London, W. T. (1993) · PubMed · Cited by 307
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., & Vousden, K. H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00418.x · Cited by 301
Nitric Oxide Induces Oxidative Damage in Addition to Deamination in Macrophage DNA
deRojas-Walker, T., Tamir, S., Ji, H., Wishnok, J. S., & Tannenbaum, S. R. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00045a020 · Cited by 254
Paterlini, P., Poussin, K., Kew, M., Franco, D., & Brechot, C. (1995) · Hepatology · doi:10.1002/hep.1840210208 · Cited by 249
Höhne, M., Schaefer, S., Seifer, M., Feitelson, M. A., Paul, D., & Gerlich, W. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08220.x · Cited by 236
Lutzker, S. G., & Levine, A. J. (1996) · Nature Medicine · doi:10.1038/nm0796-804 · Cited by 208
Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis.
Matsubara, K., & Tokino, T. (1990) · PubMed · Cited by 193
Slagle, B. L., Lee, T.-H., Medina, D., Finegold, M. J., & Butel, J. S. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199604)15:4<261::aid-mc3>3.0.co;2-j · Cited by 187
MOLECULAR EVENTS IN THE PATHOGENESIS OF HEPADNAVIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA
Robinson, M. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.297 · Cited by 175
Shirakata, Y., Kawada, M., Fujiki, Y., Sano, H., Oda, M., Yaginuma, K., Kobayashi, M., & Koike, K. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01686.x · Cited by 170
Murakami, Y., Hayashi, K., & Sekiya, T. (1991) · PubMed · Cited by 161
Genetic heterogeneity of hepatocellular carcinoma.
Unsal, H., Yakicier, C., Marçais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K. J., & Ozturk, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.822 · Cited by 161
Natoli, G., Avantaggiati, M. L., Chirillo, P., Costanzo, A., Artini, M., Balsano, C., & Levrero, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.989 · Cited by 144
Qadri, I., Conaway, J. W., Conaway, R. C., Schaack, J. B., & Siddiqui, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10578 · Cited by 138
Hepatitis B and C viruses in the development of hepatocellular carcinoma
Yu, M., & Chen, C. (1994) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)90020-5 · Cited by 137
Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., & Maeda, S. (1994) · PubMed · Cited by 135
Kumar, V., Jayasuryan, N., & Kumar, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5647 · Cited by 131
Soini, Y., Chia, S.-C., Bennett, W. P., Groopman, J. D., Wang, J.-S., DeBenedetti, V. M. G., Cawley, H., Welsh, J.-A., Hansen, C., Bergasa, N. V., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.5.1007 · Cited by 128
Self-citationTumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., & Sugimachi, K. (1993) · PubMed · Cited by 123
The Chemoattractant Properties of Comedonal Components
Puhvel, S. M., & Sakamoto, M. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12529815 · Cited by 111
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
Nitric Oxide Synthase Expression Is Induced in Hepatocytes in Vivo during Hepatic Inflammation
Geller, D. A., Silvio, M. D., Nussler, A. K., Wang, S. C., Shapiro, R. A., Simmons, R. L., & Billiar, T. R. (1993) · Journal of Surgical Research · doi:10.1006/jsre.1993.1164 · Cited by 65
Self-citationThe Hepatitis B Virus Transactivator Protein, HBx, Interacts with Single-stranded DNA (ssDNA)
Qadri, I., Ferrari, M. E., & Siddiqui, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15443 · Cited by 38
Cited by
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
Roulston, A., Marcellus, R. C., & Branton, P. E. (1999) · Annual Review of Microbiology · doi:10.1146/annurev.micro.53.1.577 · Cited by 749
Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210279 · Cited by 621
Self-citationThe Human Papillomavirus E6 protein and its contribution to malignant progression
Mantovani, F., & Banks, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204869 · Cited by 514
The Enigmatic X Gene of Hepatitis B Virus
Bouchard, M. J., & Schneider, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12725-12734.2004 · Cited by 498
Metadata
- Authors
- Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-12-23
- Volume
- 94
- Issue
- 26
- Pages
- 14707-14712
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2034296773
- Cited by
- 333
- References
- 44
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.